Singapore markets close in 27 minutes

IQVIA Holdings Inc. (IQV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
235.84+3.53 (+1.52%)
At close: 04:03PM EST
232.10 -3.74 (-1.59%)
After hours: 07:09PM EST

IQVIA Holdings Inc.

4820 Emperor boulevard
Durham, NC 27703
United States
919 998 2000

IndustryDiagnostics & Research
Full-time employees85,000

Key executives

NameTitlePayExercisedYear born
Mr. Ari BousbibChairman, Pres & CEO9.55MN/A1961
Mr. Ronald E. BruehlmanExec. VP & CFO2.67MN/A1961
Mr. Eric M. SherbetExec. VP, Gen. Counsel & Sec.1.37MN/A1964
Mr. Kevin C. KnightlyPres of Corp. Strategy & Enterprise Networks1.45MN/A1961
Ms. Keriann CherofskySr. VP, Corp. Controller & Principal Accounting OfficerN/AN/A1984
Dr. Jeffrey A. SpaederSr. VP, Global Chief Medical & Scientific OfficerN/AN/AN/A
Mr. Karl GuenaultSr. VP & Chief Information OfficerN/AN/AN/A
Mr. Nicholas ChildsSr. VP of Investor Relations & TreasuryN/AN/AN/A
Ms. Trudy SteinChief HR Officer & Exec. VPN/AN/AN/A
Dr. Cynthia L. VerstPres of Design & Delivery InnovationN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Corporate governance

IQVIA Holdings Inc.’s ISS governance QualityScore as of 1 February 2023 is 9. The pillar scores are Audit: 6; Board: 9; Shareholder rights: 9; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.